Current Protein Identity:P60484 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1D5R Crystal Structure of the PTEN Tumor Suppressor Deposited 1999-10-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 7–285(279 aa) Fragment:RESIDUES 7-353
Chain A 310–353(44 aa) Fragment:RESIDUES 7-353
Mutation:RESIDUES 286-309 ARE REPLACED BY VAL Mutation:RESIDUES 286-309 ARE REPLACED BY VAL TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;NA/K TARTRATE, 5% GLYCEROL, 100MM TRIS-CL, 10MM DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.10 Å R-free 0.276
2KYL Solution structure of MAST2-PDZ complexed with the C-terminus of PTEN Deposited 2010-06-01 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 391–403(13 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 7.5;298 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition 0.6mM [U-100% 13C; U-100% 15N] PDZ-domain-1, 1.2mM PTEN-2, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
4O1V SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer Deposited 2013-12-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 354–368(15 aa) Fragment:UNP residues 354-368
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;100 mM Tris, 100 mM sodium malonate, 36% PEG400, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.00 Å R-free 0.221
5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric(1) Consistent with protein count
Chain A 14–351(338 aa) Fragment:PTEN wt 14-351 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.40 Å R-free 0.211
5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric(1) Consistent with protein count
Chain B 14–351(338 aa) Fragment:PTEN wt 14-351 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.40 Å R-free 0.211
5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric(1) Consistent with protein count
Chain C 14–351(338 aa) Fragment:PTEN wt 14-351 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.40 Å R-free 0.211
5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric(1) Consistent with protein count
Chain D 14–351(338 aa) Fragment:PTEN wt 14-351 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.40 Å R-free 0.211
5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 VO4 VANADATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.50 Å R-free 0.204
5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.50 Å R-free 0.204
5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 VO4 VANADATE ION × 1 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.50 Å R-free 0.204
5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
Resolution 2.50 Å R-free 0.204
5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
Resolution 2.20 Å R-free 0.221
5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
Resolution 2.20 Å R-free 0.221
5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
Resolution 2.20 Å R-free 0.221
5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 14–351(338 aa) Fragment:PTEN wt 7-353 delta 286-309
Mutation:Deletion 286-309 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
Resolution 2.20 Å R-free 0.221
7JUK Crystal structure of PTEN with a tetra-phosphorylated tail (4p-crPTEN-13sp-T2, SDTTDSDPENEG) Deposited 2020-08-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 7–285(279 aa)
Chain A 310–353(44 aa)
Chain A 378–390(13 aa)
Not recorded PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;1.2 M DL-malic acid
Resolution 3.15 Å R-free 0.289
7JUL Crystal structure of non phosphorylated PTEN (n-crPTEN-13sp-T1, SDTTDSDPENEG) Deposited 2020-08-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 7–285(279 aa)
Chain A 310–353(44 aa)
Chain A 378–390(13 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293.15 K;1:1 volume of well solution: 100 mM Bis-Tris propane pH 7.0, 1.2 M DL-malic acid
Resolution 2.53 Å R-free 0.234
7JVX Crystal structure of PTEN (aa 7-353 followed by spacer TGGGSGGTGGGSGGTGGGCY ligated to peptide pSDpTpTDpSDPENEPFDED) Deposited 2020-08-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–403(403 aa)
Not recorded PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;300 mM citrate
Resolution 3.20 Å R-free 0.296
7PC7 The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of PTEN Deposited 2021-08-03 Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 394–403(10 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) CA CALCIUM ION × 6 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Tris 8.5, 22 % v/v PEG Smear Broad
Resolution 2.10 Å R-free 0.218
7PC7 The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of PTEN Deposited 2021-08-03 Assembly 2 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 394–403(10 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) CA CALCIUM ION × 6 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Tris 8.5, 22 % v/v PEG Smear Broad
Resolution 2.10 Å R-free 0.218
8X3S Crystal structure of human WDR5 in complex with PTEN Deposited 2023-11-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 115–148(34 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M lithium sulfate monohydrate, 0.1 M HEPES at pH 7.5, 25% w/v polyethylene glycol 3350
Resolution 1.87 Å R-free 0.259